|
|
|
25/08/2008
Doxa receives FDA-approval for dental cement, XeraCem
 Read more »
28/07/2008
Ökad nordisk acceptans för mätning av astma
Read more »
24/07/2008
Exiqon Receives the 2008 Frost & Sullivan Growth Strategy Leadership Award
Read more »
15/07/2008
Study Shows Use of AdvanDx’s PNA FISH™ Test Was Associated With An 82%
Reduction in Intensive Care Unit Mortality Rates From Staphylococcus aureus
Bloodstream Infections.
Read more »
27/06/2008
Kina öppnar upp för Aerocrines astmatest
Read more »
26/06/2008
Orexo report Abstral (Rapinyl) approval in Europe
Read more »
11/06/2008
Symphogen enters into strategic collaboration with Genentech for antibody therapeutics in infectious disease
Read more »
10/06/2008
Doxa har lämnat in FDA-ansökan för Xeraspine®
Read more »
10/06/2008
Doxa files application for FDA-registration of Xeraspine®
Read more »
26/05/2008
Doxa har lämnat in registreringsansökan för XeraCem™ till den amerikanska registreringsmyndigheten FDA
Read more »
26/05/2008
Genombrottsorder på svenska marknaden
Read more »
19/05/2008
Sophion announces large expansion in China
Read more »
25/04/2008
NeuroSearch indleder pivotalt fase III program med ACR16 til behandling af Huntingtons sygdom
Read more »
22/04/2008
AngioGenetics Sweden AB ingår avtal om försäljning av forskningsverksamheten till BioInvent International AB
Read more »
07/04/2008
OxThera genomför registreringsstudie på Primär Hyperoxaluri med Oxabact™
Read more »
07/04/2008
Pivotal study is being conducted with Oxabact™ for the treatment of Primary Hyperoxaluria
Read more »
27/03/2008
AdvanDx Receives Frost & Sullivan’s Rapid In-Vitro Diagnostic Technology Innovation of the Year Award
Read more »
18/03/2008
ONCOlog Medical tar in 25 miljoner kr för att utveckla produkter för effektivare strålbehandling av cancer
Read more »
18/03/2008
ONCOlog Medical raises SEK 25 million to develop products for more effective cancer radiation therapy
Read more »
04/03/2008
Genombrott i USA för svensk astmaprodukt
Read more »
15/02/2008
Atlas Antibodies AB and Sigma-Aldrich Establish Exclusive Distibution Partnership
Read more »
11/02/2008
Aerocrine tecknar distributörsavtal med Chest i Japan
Read more »
06/02/2008
Biovitrum og Symphogen har færdiggjort succesfyldt fase I klinisk forsøg med et rekombinant polyklonalt antistof
Read more »
06/02/2008
Biovitrum and Symphogen have Successfully Completed Phase I Clinical Trial with Recombinant Polyclonal Antibody
Read more »
15/01/2008
Action Pharma raises EUR 15 million from international investors
Read more »
21/01/2008
Exiqon enters into a definitive agreement to accquire Oncotech Inc and enters the market for cancer molecular diagnostics
Read more »
|
